Literature DB >> 19950205

Bone marrow mesenchymal stem cells.

Masanobu Ohishi1, Ernestina Schipani.   

Abstract

Following the identification of bone marrow multipotent cells that could adhere to plastic and differentiate along numerous mesenchymal lineages in vitro, a considerable effort has been invested in characterizing and expanding these cells, which are now called "mesenchymal stem cells" (MSCs), in vitro. Over the years, numerous lines of evidence have been provided in support of their plasticity, their extraordinary immunomodulatory properties, their potential use for tissue engineering purposes, as well as their ability to be recruited to sites of injury, where they might contribute a "natural in vivo system for tissue repair." Moreover, some studies have attempted the characterization of their cell-surface specific antigens and of their anatomical location in vivo. Lastly, it has been shown that similar cells could be also isolated from organs other than the bone marrow. Despite this impressive body of investigations, numerous questions related to the developmental origin of these cells, their proposed pluripotency, and their role in bone modeling and remodeling and tissue repair in vivo are still largely unanswered. In addition, both a systematic phenotypic in vivo characterization of the MSC population and the development of a reproducible and faithful in vivo assay that would test the ability of MSCs to self-renew, proliferate, and differentiate in vivo are just beginning. This brief review summarizes the current knowledge in the field of study of MSCs and the outstanding questions. (c) 2009 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2010        PMID: 19950205     DOI: 10.1002/jcb.22399

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  42 in total

1.  The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells.

Authors:  YuJie Xing; AnLin Lv; Li Wang; XueBo Yan
Journal:  Mol Cell Biochem       Date:  2011-09-21       Impact factor: 3.396

2.  Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes.

Authors:  Krishna C Vallabhaneni; Hermann Haller; Inna Dumler
Journal:  Stem Cells Dev       Date:  2012-07-13       Impact factor: 3.272

3.  Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.

Authors:  Najib El Haddad; Dean Heathcote; Robert Moore; Sunmi Yang; Jamil Azzi; Bechara Mfarrej; Mark Atkinson; Mohamed H Sayegh; Jeng-Shin Lee; Philip G Ashton-Rickardt; Reza Abdi
Journal:  Blood       Date:  2010-11-12       Impact factor: 22.113

4.  The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart.

Authors:  Yeyou Liang; Qiuxiong Lin; Jiening Zhu; Xiaohong Li; Yongheng Fu; Xiao Zou; Xiaoying Liu; Honghong Tan; Chunyu Deng; Xiyong Yu; Zhixin Shan; Weiwei Yuan
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

Review 5.  PTH and stem cells.

Authors:  M Ohishi; E Schipani
Journal:  J Endocrinol Invest       Date:  2011-03-22       Impact factor: 4.256

Review 6.  Adult stem cell-based apexogenesis.

Authors:  Yao Li; Li-Hong Shu; Ming Yan; Wen-Yong Dai; Jun-Jun Li; Guang-Dong Zhang; Jin-Hua Yu
Journal:  World J Methodol       Date:  2014-06-26

7.  Modulation of osteogenic, adipogenic and myogenic differentiation of mesenchymal stem cells by submicron grooved topography.

Authors:  Peng-Yuan Wang; Wen-Tyng Li; Jiashing Yu; Wei-Bor Tsai
Journal:  J Mater Sci Mater Med       Date:  2012-08-19       Impact factor: 3.896

Review 8.  Role of bone marrow adipocytes in leukemia and chemotherapy challenges.

Authors:  Azin Samimi; Majid Ghanavat; Saeid Shahrabi; Shirin Azizidoost; Najmaldin Saki
Journal:  Cell Mol Life Sci       Date:  2019-02-04       Impact factor: 9.261

Review 9.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

10.  Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.

Authors:  Parnian Kalbasi Anaraki; Margret Patecki; Jan Larmann; Sergey Tkachuk; Kerstin Jurk; Hermann Haller; Gregor Theilmeier; Inna Dumler
Journal:  Stem Cells Dev       Date:  2013-12-11       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.